Jeong, Won Il,Kim, Myung Ho,Jeong, Jong Min,Kim, So Yeon,Kim, Sun Chang
申请号：
AU2017201862
公开号：
AU2017201862A1
申请日:
2017.03.20
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2017201862A120180222.pdf#####[Abstract] The present invention relates to a composition for preventing or treating liver cancer containing ginsenoside F2 as an active ingredient. Specifically, the composition according to the present invention kills liver cancer cells, specifically inhibits the formation of liver cancer, 5 and reduces the expression of alanine aninotransferase (ALT) or aspartate aminotransferase (AST), without affecting normal hepatocytes, and thus can be usefully used as a therapeutic agent for liver cancer.1/10 [DRAWINGS] [FIG. la] Hep3B *~120 o 80； 40 0 0 0 102 0 30 40 50 60 GF2 (pM)
